期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Polo样激酶1抑制剂临床前和早期临床研究进展

Preclinical Research and Early Clinical Research of Polo-like Kinase 1 Inhibitors
下载PDF
导出
摘要 Polo样激酶1(PLK 1)是一种高度保守的丝氨酸/苏氨酸蛋白激酶,在细胞有丝分裂过程中发挥重要作用。人类80%的肿瘤类型中,PLK1高度表达。PLK1的过表达与部分肿瘤的预后不良和整体存活率较低相关。PLK1抑制剂对有丝分裂的不同阶段具有干扰作用,如中心体的成熟、纺锤体的形成、染色体的分离和胞质分裂等,最终导致肿瘤细胞凋亡。综述PLK1抑制剂临床前和早期临床的研究进展。 Polo-like kinase 1（PLK1） is a highly conserved serine/threonine protein kinases that plays a key role in regulation of mitosis.In about 80% of human tumors,of various origins,PLK1 is over expressed.Over-expression of PLK1 is associated with a poor prognosis in several tumor types and a lower overall survival rate.PLK1 inhibitor can interfere with different stages of mitosis,such as centrosome maturation,spindle formation,chromosome separation,and cytokinesis.This review includes an overview of PLK1 inhibitor in clinical and preclinical development.
作者 孙天宇 孙建国 王广基
机构地区 中国药科大学药代重点实验室
出处 《药学与临床研究》 2011年第2期146-150,共5页 Pharmaceutical and Clinical Research
关键词 POLO样激酶1 有丝分裂 Polo样激酶1抑制剂 肿瘤 Polo-like kinase Mitosis Polo-like kinase 1 inhibitor Tumor
分类号 R979.1 [医药卫生—药品]
  • 相关文献

参考文献29

  • 1Liu X,Erikson RL.Polo-like kinase (PLK)1 depletion induces apoptosis in cancer cells[J].Proc Natl A cad Sci,2003,100(10):5789-94.
  • 2Lowery DM,Lim D,Yaffe MB.Structure and function of Polo-like kinases[J].Oncogene,2005,24(2):248-59.
  • 3Toyoshima-Morimoto F,Taniguchi E,Nishida E.Plk1 promotes nuclear translocation of human Cdc25Cduring prophase[J].EMBO Rep,2002,3(4):341-8.
  • 4Matsumura S,Toyoshima F,Nishida E.Polo-like kinasel facilitates chromosome alignment during pro -metaphase through BubR1[J].J Biol Chem,2007,282(20):15217 -27.
  • 5van de Weerdt BC,Medema RH.Polo-like kinases:a team in control of the division[J].Cell Cycle,2006,5 (8):853-64.
  • 6Takaki T,Trenz K,Costanzo V,et al.Polo-like kinase 1 reaches beyond mitosis-cytokinesis DNA damage response,and development[J].Curr Opin Cell Biol,2008,20(6):650-60.
  • 7Petronczki M,Lénárt P,Peters JM.Polo on the Risefrom Mitotic Entry to Cytokinesis with PLK1[J].Dev Cell,2008,14(5):646-59.
  • 8Wasch R,Hasskarl J,Schnerch D,et al.BI2536-Targeting the Mitotic Kinase Polo-Like Kinase 1 (Plk1)[J].Recent Results Cancer Res,2010,184:215-8.
  • 9Steegmaier M,Hoffmann M,Baum A,et al.BI 2536,a potent and selective inhibitor of Polo-like kinase 1,inhibits tumor growth in vivo[J].Curr Biol,2007,17(4):316-22.
  • 10Mross K,Frost A,Steinbild S,et al.Phase Ⅰ dose escalation and pharmacokinetic study of BI 2536,a novel Polo-like kinase 1 inhibitor,in patients with advanced solid tumors[J].J Clin Oncol,2008,26(34):5511-7.
药学与临床研究
2011年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部